BRIEF-SPIMACO Q1 Net Profit SAR 65.1 Million

SPIMACO
Tadawul All Shares Index

SPIMACO

2070.SA

0.00

Tadawul All Shares Index

TASI.SA

0.00

May 3 (Reuters) - SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORP 2070.SE:

  • SPIMACO Q1 SALES SAR 423.8 MILLION

  • SPIMACO Q1 NET PROFIT SAR 65.1 MILLION

  • SPIMACO Q1 SAW DECREASE IN REVENUE FROM PRIVATE SALES BY 33%

  • SPIMACO Q1 SAW INCREASE IN PROVISION FOR IMPAIRMENT LOSSES ON FINANCIAL ASSETS BY 28%

  • SPIMACO Q1 SAW DECREASE IN OTHER INCOME BY 82%

  • SPIMACO - Q1 SAW INCREASE IN REVENUES FROM INTERNATIONAL AND GOVERNMENT SALES BY 28%

  • SPIMACO Q1 SAW INCREASE IN ZAKAT AND TAX EXPENSES BY 311%

  • SPIMACO - Q1 SAW INCREASE IN REVENUE FROM GOVERNMENT SALES BY 103%

Source text: ID:nSSE77N1dG

Further company coverage: 2070.SE


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.